CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap

Chimeric antigen receptor (CAR-T) therapy has marked a paradigm shift in the treatment of hematological malignancies and represent a promising growing field also in solid tumors. Neurotoxicity is a well‐recognized common complication of CAR-T therapy and is at the forefront of concerns for CAR-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatto, Lidia, Ricciotti, Ilaria, Tosoni, Alicia, Di Nunno, Vincenzo, Bartolini, Stefania, Ranieri, Lucia, Franceschi, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312075/
https://www.ncbi.nlm.nih.gov/pubmed/37397356
http://dx.doi.org/10.3389/fonc.2023.1206983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312075/
https://www.ncbi.nlm.nih.gov/pubmed/37397356
http://dx.doi.org/10.3389/fonc.2023.1206983

Ejemplares similares